EXCLUSIVE: Prenetics, Professor Dennis Lo Aim To Make Early Cancer Detection 'Universally Accessible Necessity' With $200M Joint Venture
Prenetics Global Limited (NASDAQ: PRE), a genomics and precision oncology company, and Professor Dennis Lo announced Sunday they have entered a partnership to establish an early cancer detection screening joint venture, Insighta.
